Clifton R. LaDuane 4

4 · ZEVRA THERAPEUTICS, INC. · Filed Jan 7, 2026

Form 4

Period: 2025-12-31

Other

Transactions

Exercise/Conversion
Common Stock
2025-12-31+140,667→ 192,028 total
Tax Payment
Common Stock
2025-12-31$8.96/sh−48,513$434,676→ 143,515 total
Exercise/Conversion
Restricted Stock Unit
2025-12-31−86,667→ 0 total
→ Common Stock (86,667 underlying)
Exercise/Conversion
Restricted Stock Unit
2025-12-31−34,000→ 0 total
→ Common Stock (34,000 underlying)
Exercise/Conversion
Performance Stock Unit
2025-12-31−20,000→ 0 total
→ Common Stock (20,000 underlying)

Footnotes (5)

[F1]Shares issued upon vesting of restricted stock units and performance stock units on December 31, 2025.
[F2]Shares withheld to cover withholding taxes for the vested restricted stock units and performance stock units.
[F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
[F4]The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025.
[F5]Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock.

Documents

1 file